FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)

DEERFIELD, Ill., Jan. 27, 2016 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc., (Takeda) (TSE: 4502) today announced that the United States (U.S.) Food and Drug Administration (FDA) approved Dexilant SoluTab delayed-release orally disintegrating...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news